NCT06565871View on ClinicalTrials.gov

A Study of HRS9531 Injection in Obese Subjects With Obstructive Sleep Apnea

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Weight Management
Interventions
DRUG

HRS9531 Injection

Titration administration, SC

DRUG

HRS9531 Injection

Titration administration, SC

DRUG

Placebo Injection

SC

All Listed Sponsors
lead

Fujian Shengdi Pharmaceutical Co., Ltd.

INDUSTRY

NCT06565871 - A Study of HRS9531 Injection in Obese Subjects With Obstructive Sleep Apnea | Biotech Hunter | Biotech Hunter